Globus Medical (GMED) PT Raised to $103 at Barclays
Tweet
Share
E-mailGet Alerts GMED Hot Sheet
Price: $86.25 +1.89%
Rating Summary:
22 Buy, 7 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 20 | New: 24
Rating Summary:
22 Buy, 7 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 20 | New: 24
Join SI Premium – FREE
Barclays analyst Matt Miksic raised the price target on Globus Medical (NYSE: GMED) to $103.00 (from $100.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Rolls-Royce Holdings Plc. (RR/:LN) (RYCEY) PT Raised to GBP16.25 at JPMorgan
- Luk Fook Holdings International Ltd. (590:HK) (LKFLF) PT Raised to HK$31.80 at Citi
- Budweiser Brewing Company APAC Limited (1876:HK) (BDWBF) PT Lowered to HK$7.60 at Goldman Sachs
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
